← Back to patent-cliff list
Bixalomer
Tier C — Watch / tradeBixalomer
安进
Originator
2012
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：Phosphates
Brand：Kiklin
Indications (approved)：高磷血症
Regional status
US
无进展
2006-06-01
EU
-
China
-
Japan
批准上市
2012-03-30
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Bixalomer?
Approved indications include: 高磷血症.
When does the Bixalomer patent expire?
No public expiry year is available for Bixalomer yet; this page updates once verified.
How do I get a quote for Bixalomer intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24